HuiChuan J Lai1,2, Lyanne H Chin1, Sangita Murali1, Taiya Bach1, Danielle Sander1, Philip M Farrell2,3. 1. Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA. 2. Department of Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin, USA. 3. Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Abstract
BACKGROUND: The variable response to fat-soluble vitamin supplementation in young children with cystic fibrosis (CF), and factors contributing to this variability, remain under-investigated. OBJECTIVE: To determine if recommended supplement doses normalize serum vitamins A (retinol), D (25-hydroxy-vitamin D, 25OHD), and E (α-tocopherol), and identify factors predictive of achieving sufficiency, in children with CF in the first 3 years of life. DESIGN: We studied 144 infants born during 2012-2017 and diagnosed with CF through newborn screening. Serum retinol, 25OHD, α-tocopherol and plasma cytokines interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor (TNF)-α were measured in early infancy and yearly thereafter. Vitamin supplement intakes and respiratory microbiology were assessed every 1-2 months in infancy and quarterly thereafter. RESULTS: The prevalence of vitamin D insufficiency (<30 ng/ml) at all ages combined was significantly higher (22%) compared to vitamin A (<200 ng/ml, 3%) and vitamin E (<5 µg/ml, 5%). All children were vitamin A sufficient by age 2 years. Vitamin E insufficiency was rare. Only 42% were early responders of vitamin D and 17% remain insufficient despite high supplement intakes. IL-6 was positively correlated, while IL-8, IL-10, and TNF-α were negatively correlated, with retinol and 25OHD. Multiple regression analysis revealed that supplement dose, season, α-tocopherol, pancreatic insufficiency, respiratory infections and IL-10 were significant predictors of 25OHD. CONCLUSION: Diagnosis through newborn screening coupled with supplementation normalized serum retinol and α-tocopherol in almost all infants with CF by age 3 years. However, response to vitamin D supplements in young children with CF occurred later and variably despite early and sustained supplementation.
BACKGROUND: The variable response to fat-soluble vitamin supplementation in young children with cystic fibrosis (CF), and factors contributing to this variability, remain under-investigated. OBJECTIVE: To determine if recommended supplement doses normalize serum vitamins A (retinol), D (25-hydroxy-vitamin D, 25OHD), and E (α-tocopherol), and identify factors predictive of achieving sufficiency, in children with CF in the first 3 years of life. DESIGN: We studied 144 infants born during 2012-2017 and diagnosed with CF through newborn screening. Serum retinol, 25OHD, α-tocopherol and plasma cytokines interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor (TNF)-α were measured in early infancy and yearly thereafter. Vitamin supplement intakes and respiratory microbiology were assessed every 1-2 months in infancy and quarterly thereafter. RESULTS: The prevalence of vitamin D insufficiency (<30 ng/ml) at all ages combined was significantly higher (22%) compared to vitamin A (<200 ng/ml, 3%) and vitamin E (<5 µg/ml, 5%). All children were vitamin A sufficient by age 2 years. Vitamin E insufficiency was rare. Only 42% were early responders of vitamin D and 17% remain insufficient despite high supplement intakes. IL-6 was positively correlated, while IL-8, IL-10, and TNF-α were negatively correlated, with retinol and 25OHD. Multiple regression analysis revealed that supplement dose, season, α-tocopherol, pancreatic insufficiency, respiratory infections and IL-10 were significant predictors of 25OHD. CONCLUSION: Diagnosis through newborn screening coupled with supplementation normalized serum retinol and α-tocopherol in almost all infants with CF by age 3 years. However, response to vitamin D supplements in young children with CF occurred later and variably despite early and sustained supplementation.
Authors: M N Bronstein; R J Sokol; S H Abman; B A Chatfield; K B Hammond; K M Hambidge; C D Stall; F J Accurso Journal: J Pediatr Date: 1992-04 Impact factor: 4.406
Authors: Natalie T Mills; Margie J Wright; Anjali K Henders; Darryl W Eyles; Bernhard T Baune; John J McGrath; Enda M Byrne; Narelle K Hansell; Eva Birosova; James G Scott; Nicholas G Martin; Grant W Montgomery; Naomi R Wray; Anna A E Vinkhuyzen Journal: Twin Res Hum Genet Date: 2014-12-03 Impact factor: 1.587
Authors: Drucy Borowitz; Susan S Baker; Linda Duffy; Robert D Baker; Laura Fitzpatrick; Joyce Gyamfi; Kerry Jarembek Journal: J Pediatr Date: 2004-09 Impact factor: 4.406
Authors: M S Marcus; S A Sondel; P M Farrell; A Laxova; P M Carey; R Langhough; E H Mischler Journal: Am J Clin Nutr Date: 1991-09 Impact factor: 7.045
Authors: Jorrit Jv de Vries; Anne B Chang; Catherine M Bonifant; Elizabeth Shevill; Julie M Marchant Journal: Cochrane Database Syst Rev Date: 2018-08-09
Authors: Leslie Huang; HuiChuan J Lai; Nicholas Antos; Michael J Rock; Fadi Asfour; Michelle Howenstine; Jonathan M Gaffin; Philip M Farrell Journal: Pediatr Pulmonol Date: 2022-06-25